<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>    Colon <br />  <br />                                     ORIGINAL ARTICLE <br />  <br />                                     Reduced LIMK2 expression colorectal cancer <br />                                     re&#239;&#172;&#8218;ects role limiting stem cell proliferation <br />                                     Filipe C Louren&#195;&#167;o,1 June Munro,1 Jennifer Brown,1 Julia Cordero,1 Rhoda Stefanatos,1 <br />                                     Karen Strathdee,1 Clare Orange,2 Stephan M Feller,3 Owen J Sansom,1 Marcos Vidal,1 <br />                                     Graeme Murray,4 Michael F Olson1 <br />  <br /> &#226;&#8211;&#184; Additional material            ABSTRACT <br /> published online  view      Objective Colorectal cancer (CRC) major                      Signi&#239;&#172;?cance study visit journal online <br /> (http://dx.doi.org/10.1136/         contributor cancer mortality morbidity. LIM kinase <br /> gutjnl-2012-303883).                2 (LIMK2) promotes tumour cell invasion metastasis. <br /> 1                                   objectives study determine               known subject? <br />   Beatson Institute Cancer <br /> Research, Glasgow, UK               LIMK2 expression associated CRC progression              &#226;&#8211;&#184; LIM kinases overexpressed tumour <br /> 2 <br />   Department Pathology,          patient outcome, use genetically modi&#239;&#172;?ed                types. <br /> Division Cancer Sciences         Drosophila mice determine LIMK2 deletion              &#226;&#8211;&#184; contribute regulation actomyosin Molecular Pathology,            affects gastrointestinal stem cell regulation tumour <br /> Western In&#239;&#172;?rmary, <br />                                                                                                        cytoskeletal dynamics, play roles Glasgow, UK <br />                                     development.                                                       cell motility, invasion metastasis. <br /> 3 <br />   Weatherall Institute           Design LIMK2 expression activity measured               &#226;&#8211;&#184; possible involvement LIM kinases CRC <br /> Molecular Medicine, John            immunostaining tumours CRC-prone mice,                     unknown. <br /> Radcliffe Hospital, University   human CRC cell lines 650 human tumours. LIMK <br /> Oxford, Oxford, UK <br /> 4                                   knockdown Drosophila Limk2 deletion mice                new &#239;&#172;?ndings? <br />   Department Pathology,                                                                           &#226;&#8211;&#184; LIMK2 expression substrate <br /> Division Applied Medicine,       allowed assessment contributions School Medicine              gastrointestinal stem cell homeostasis tumour                  phosphorylation progressively decrease Dentistry, University            development.                                                       tumour stage. <br /> Aberdeen, Aberdeen, UK              Results LIMK2 expression reduced intestinal               &#226;&#8211;&#184; Deletion dLIMK Drosophila midgut results <br />                                     tumours cancer-prone mice, human CRC              stem cell proliferation organ thickening. <br /> Correspondence Professor Michael F Olson,          cell lines tumours. Reduced LIMK2 expression             &#226;&#8211;&#184; LIMK2 deletion increases mouse intestinal stem <br /> Beatson Institute Cancer        substrate phosphorylation associated shorter             cell proliferation vitro. <br /> Research, Garscube Estate,          patient survival. Genetic analysis Drosophila midgut          &#226;&#8211;&#184; context mouse model Switchback Road, Glasgow                                                                               colitis-associated CRC, Limk2 deletion increases <br />                                     intestinal epithelial cells isolated genetically <br /> G61 1BD, UK;                                                                                           dysplasia intestinal tumour size. <br /> m.olson@beatson.gla.ac.uk           modi&#239;&#172;?ed mice revealed conserved role LIMK2                                     constraining gastrointestinal stem cell proliferation. Limk2     impact clinical practice Received 5 October 2012             deletion increased colon tumour size colitis- <br /> Revised 12 February 2013                                                                             foreseeable future? <br />                                     associated colorectal mouse cancer model.                        &#226;&#8211;&#184; study reveals actomyosin cytoskeleton <br /> Accepted 24 March 2013 <br /> Published Online              Conclusions study revealed LIMK2 expression              regulators LIMK2 patterns 12 April 2013                       activity progressively decrease advancing stage,          expression CRC distinct tumour <br />                                     supports hypothesis selective                types including breast prostate, meaning <br />                                     pressure reduced LIMK2 expression CRC relieve            drugs targeting cytoskeleton                                     negative constraints imposed gastrointestinal                 likely context-dependent effects. <br />                                     stem cells. <br />  <br />  <br />  <br />                                     INTRODUCTION                                                      actomyosin cytoskeleton provides struc- <br />                                     Colorectal cancer (CRC) common               tural underpinning gives cells shape                                     form disease men second                 allows respond changes external <br />                                     common women worldwide, major                      physicomechanical conditions. Importantly, dynamic <br />                                     contributor cancer mortality morbidity.                 reorganisation cytoskeletal structures allows <br />                                     possibility exists CRC cells             tumour cells invade local tissue ultimately <br />                                     origin derived reprogrammed                     metastasise distant sites.6 result, commonly <br />                                     epithelial cells transdifferentiated bone marrow-           held concept expression actomyosin <br />                                     derived cells,1 experimental evidence strongly sup-            regulatory proteins increase tumorigenesis <br />              Open Access            ports conclusion intestinal crypt stem cells          progression.  given multiple roles <br />           Scan access              free content           predominant source intestinal               actomyosin cytoskeleton plays cell homeostasis, <br />                                     tumours emerge.2&#226;&#8364;&#8220;5  mutations                     example, apoptosis human embryonic <br />                                     changes gene expression observed CRC                 stem cells,7 alternative possibility     cite: Louren&#195;&#167;o FC,           promote tumour initiation growth                   selection reduced expression loss acto- <br />     Munro J, Brown J, et al. Gut    effects stem cell homeostasis.                        myosin regulators cancers. <br />     2014;63:480&#226;&#8364;&#8220;493. <br />  <br />  <br /> 480                                                                                        Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883 <br />                                                                                                                                     Colon <br />  <br />    LIM kinase family consists members; LIM kinase              Technology); &#206;&#178;-catenin (BD Biosciences); GFP (Abcam); Olfm4 <br /> 1 (LIMK1) LIM kinase 2 (LIMK2), play central roles              (Abcam); Bmi1 (Cell Signaling Technology); Erk2 (gift RhoGTPase regulation actin cytoskeleton phosphor-            Chris Marshall, Institute Cancer Research); Stat1 (Cell <br /> ylating co&#239;&#172;?lin proteins Serine3 inactivating &#239;&#172;?la-            Signaling Technology). Alexa-Fluor680 (Molecular Probes) mentous actin severing activity.8 LIMK1 LIMK2 50%                IRDye800 (Rockland)-conjugated secondary antibodies overall identity 70% identity kinase domains,            detected infra-red imaging (Li-Cor Odyssey). Goat anti- regulated activation loop phosphorylation                  mouse goat anti-rabbit horseradish peroxidase-conjugated <br /> RhoGTPase effector kinases including ROCK, PAK                        antibodies Pierce. <br /> MRCK.8 LIM kinases act central network hubs regula- <br /> tion cytoskeletal dynamics proposed                Histology immunohistochemistry <br /> attractive potential cancer drug targets.9 Consistent posi-        Histology immunohistochemistry performed tive role cancer, expression LIMK1 reported             described.18 Antibodies working concentrations used elevated breast,10 11 malignant melanoma12 prostate13           immunohistochemistry immuno&#239;&#172;&#8218;uorescence fol- <br /> tumours.  studies reported <span id='am-5' about='oboInOwl:date' typeof='owl:Thing'>date</span>             lowing: LIMK2, 1:200 (Santa Cruz Biotechnology, ; examined expression LIM kinases CRC.                       Phospho-Co&#239;&#172;?lin, 1:100 (Cell Signaling Technology); GFP, 1:250 <br />    study, LIMK2 expression reduced            (BD Biosciences); Texas-Red phalloidin, 1:250 (Molecular <br /> intestinal tumours genetically modi&#239;&#172;?ed mice,                  Probes, Invitrogen); &#206;&#178;-catenin, 1:1000 (BD Biosciences). <br /> human CRC cell lines tumours. Protein levels progres-            DAB-stained slides imaged using Hamamatsu <br /> sively lower advancing tumour grade, reduced LIMK2               Nanozoomer NDP slide scanner (Hamamatsu Photonics) expression substrate protein phosphorylation asso-           Digital Slide Server (Slidepath) software. immuno&#239;&#172;&#8218;uores- <br /> ciated shorter patient survival times. Increased LIMK2 pro-          cence images Nikon A1R confocal microscope used. moter methylation observed tumours relative patient             Drosophila immuno&#239;&#172;&#8218;uorescence, tissues dissected matched normal tissue. Using genetic methods, identi&#239;&#172;?ed              phosphate-buffered saline (PBS) &#239;&#172;?xed 30&#226;&#8364;&#8220;45 min 4% <br /> repressive role LIMK2 intestinal stem cell proliferation        para-<span id='am-19' about='obo:IMR_0200017' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-20' property="oboInOwl:hasDbXref" content="KEGG:C00067" datatype="xsd:string"></span><span id='am-21' property="rdfs:label" content="Formaldehyde" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:id" content="IMR:0200017" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>formaldehyde</span>. &#239;&#172;?xation, samples washed Drosophila melanogaster mice. Using mouse model               times PBS+0.1% Triton X-100 (PBST) incubated colitis-associated CRC, determined LIM kinase 2 knock-            primary antibodies overnight 4&#194;&#176;C. Samples washed (Limk2-KO) mice increased intestinal tumour size              subjected secondary antibody staining 2 h room <br /> dysplasia. data support hypothesis select-        temperature followed washing mounting Vectashield <br /> ive pressure reduced LIMK2 expression CRC relieve               containing DAPI (Vector Laboratories, . Primary secondary <br /> negative constraints imposed gastrointestinal stem cells.              antibodies incubated PBST+0.5% bovine serum albumin. <br />                                                                           antibodies used anti-phospho-Histone 3 (1:100 dilution, <br /> MATERIALS METHODS                                                     Cell Signaling Technology), anti-GFP (1:2000 dilution Cell culture                                                              Abcam) anti-Armadillo (1:3 dilution, developed Mouse embryo &#239;&#172;?broblast cells isolated cultured                E. Wieschaus obtained Developmental Studies <br /> described D&#226;&#8364;&#8482;Abaco Olson.14 Intestinal epithelial cultures          Hybridoma Bank developed auspices National isolated cultured described Sato et al.15                  Institute Child Health Human Development main- <br /> Colorectal tumour cell lines maintained, cell lysates            tained University Iowa, Department Biology, Iowa <br /> prepared, described Emaduddin et al.16                              City, IA, USA). Primary antibodies visualised Alexa 488, <br />                                                                           Alexa 532 594-conjugated secondary antibodies (Molecular <br /> Promoter methylation                                                      Probes, Invitrogen). novo methyltransferase inhibitor treatments, SW48 cells plated plates 2&#195;&#8212;105  following           Mice <br /> day, RG108 (100 mM &#239;&#172;?nal), 5-azacytidine (5-Aza) (10 mM &#239;&#172;?nal)              Lgr5-EGFP-ires-Cre:ER-T2 (Lgr5&gt;GFP) mice described previ- 1% dimethyl sulfoxide vehicle (v/v) diluted                    ously.19 Limk2 gene-trap embryonic stem cells (sequence tag: <br /> Dulbecco&#226;&#8364;&#8482;s modi&#239;&#172;?ed eagle medium supplemented 10% fetal               RRE287; MMRRC stock # 001883-UCD) obtained calf serum applied cells 48 h 37&#194;&#176;C. Genomic DNA             BayGenomics used blastocyst injections Beatson cell lines tissues prepared using QIAamp DNA                Institute using standard methods. Experimental mice Mini Kit (Qiagen). Bisulphite conversion genomic DNA               mixed C57BL/6J 129/ola strain background. Limk2-KO mice <br /> performed using EZ DNA Methylation-Gold Kit (Zymo                     viable born Mendelian ratios (observed genotype birth <br /> Research), followed PCR using custom-designed primers                  49/183=26.8%) macroscopic abnormalities. proce- <br /> (Invitrogen). PCR products puri&#239;&#172;?ed using QIAquick                dures performed appropriate licences according PCR Puri&#239;&#172;?cation Kit (Qiagen) cloned using 2.1-TOPO                UK Home Of&#239;&#172;?ce guidelines. <br /> vector, transformation TOP10 Escherichia coli <br /> (Invitrogen). Blue/white screening utilised select positive        Colitis-associated CRC (AOM+DSS) <br /> colonies DNA isolation sequencing. Sequencing analysis            day 1, mice genotype (8&#226;&#8364;&#8220;12-week-old littermates) using CLC Genomics V.5.0 software.                               weighed injected intraperitoneally 12.5 mg/kg                                                                           azoxymethane (AOM) solution (Sigma-Aldrich). day 6 Cell extraction immunoblotting                                        drinking supply &#239;&#172;?lled dextran sodium sulfate (DSS) solu- cell lysates prepared western blotted                   tion (DSS salt, MW36 000&#226;&#8364;&#8220;56 000 Da, MP Biomedicals). day <br /> described previously.17 Primary antibodies used routinely            8 drinking supply re&#239;&#172;?lled DSS solution day 10 <br /> used 1:1000 western blotting. Antibodies used                 replaced autoclaved water 14 days. cycle (5 days DSS <br /> co&#239;&#172;?lin (Cell Signaling Technology); LIMK1 (Cell Signaling                 plus 14 days water) repeated times. DSS regimes <br /> Technology); LIMK2 (Santa Cruz Biotechnology, );                      following: cycle 1&#226;&#8364;&#8220;1%; cycle 2&#226;&#8364;&#8220;1.5%; cycle 3&#226;&#8364;&#8220;1.5%. &#206;&#177;-tubulin   (&#207;&#402;-Aldrich);    phospho-co&#239;&#172;?lin    (Cell  Signaling            mice culled dissected approximately day 70. Tumour <br />  <br /> Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883                                                                  481 <br />   Colon <br />  <br /> volume determined assuming quasi half-spherical              Statistical analysis <br /> shapeV &#194;&#188; &#194;&#189;&#195;&#176;4=3pr3 &#195;&#382;=2 .                                                 Unless indicated, statistical signi&#239;&#172;?cance determined                                                                         way analysis variance followed Tukey&#226;&#8364;&#8482;s post-hoc tests. <br /> Lgr5-GFP+ stem cell FACS sorting, RNA puri&#239;&#172;?cation                   Data shown means&#194;&#177;SD unless indicated. Box plots indi- <br /> quantitative reverse transcriptase PCR                                  cate medians bounded quartiles whiskers denoting 5th&#226;&#8364;&#8220; <br /> Crypt-villus organoids removed matrigel centrifugation          95th percentiles. Survival analysis performed SPSS freshly isolated intestinal crypts single-cell dissociated   V.19 using method Kaplan&#226;&#8364;&#8220;Meier log-rank test TrypLE (Life Technologies) combined DNAse (2000 U/               compare individual groups. <br /> ml) 30 min 37&#194;&#176;C. Dissociated cells passed 40 mm cell strainer incubated DAPI (1:500) dead <br /> cell exclusion. DAPI&#226;&#710;&#8217;/GFP+-positive cells analysed             RESULTS <br /> sorted using FacsAria (BD Bioscience). Cells sorted         LIMK2 expression human CRC organoid culture medium plus Y27632 (10 mM). RNA               determine LIMK2 protein levels affected puri&#239;&#172;?ed approximately 5000 GFP+ cells using                    CRC cell lines, &#239;&#172;?rst validated speci&#239;&#172;?city antibody <br /> Arcturus PicoPure RNA isolation kit (Applied Biosystems).               recognises LIMK2a LIMK2b variants17 western <br /> Complementary DNA synthesised using Quantitect                  blotting lysates wild-type Limk2 +/&#226;&#710;&#8217; Limk2 &#226;&#710;&#8217;/&#226;&#710;&#8217; mouse <br /> Reverse Transcription Kit (Qiagen). Quantitative reverse tran-          embryo &#239;&#172;?broblasts (&#239;&#172;?gure 1A; non-speci&#239;&#172;?c band denoted ). <br /> scriptase (RT)-PCR primers murine Limk2, Lgr5, Olfm4,               Western blotting lysates panel CRC cell lines revealed <br /> Ascl2, CD44, Bmi1, 18s Hprt acquired Qiagen               expression LIMK1, ERK2 LIM kinase substrate <br /> (Quantitect Primer Assay).                                              co&#239;&#172;?lin relatively constant, LIMK2 expression                                                                         variable numerous cell lines (&#239;&#172;?gure 1B). LIMK2 expression                                                                         HCT116 SW48 cells lower compared normal human <br /> X-gal staining mouse frozen sections <br />                                                                         colon tissue (&#239;&#172;?gure 1C) protein lysate mass/mass basis (&#239;&#172;?rst <br /> Tumour adjacent normal tissue specimens Ah-CreER <br />                                                                         second vs lane) normalised &#206;&#177;-tubulin levels <br /> APCFl/+ PTENFl/+ Limk2+/&#226;&#710;&#8217; mice isolated, washed PBS <br />                                                                         (vs fourth lane). determine epigenetics mounted OCT (Tissue-Tek, Sakura) immediately <br />                                                                         in&#239;&#172;&#8218;uencing LIMK2 expression, chose SW48 cells exem- <br /> frozen using Cryospray (CellPath . 14 mm  <br />                                                                         plar treated novo methyltransferase inhibi- <br /> ness sections stained using &#206;&#178;-Gal Staining Kit <br />                                                                         tors RG108 5-Aza.24 treatments showed elevated <br /> (Invitrogen, Life Technologies) 48 h 37&#194;&#176;C. <br />                                                                         LIMK2 levels 48 h (&#239;&#172;?gure 1D). Sequencing bisul&#239;&#172;?te <br />                                                                         converted genomic DNA revealed methylation 7 CpG <br /> Flies                                                                   islands ( positions indicated vertical red lines &#239;&#172;?gure 1D <br /> Fly cultures incubations carried standard               line diagram) LIMK2a promoter (&#226;&#710;&#8217;629 &#226;&#710;&#8217;541 relative molasses media, food changes 2 days, 25&#194;&#176;C            start transcription) seven CpG islands controlled 12 h light-dark cycles described 20 RNAi           LIMK2b promoter (+104 +314) reduced 5-Aza <br /> experiments, male dLIMK 26 294 28 948 &#239;&#172;&#8218;y lines               treatment (&#239;&#172;?gure 1D, pie charts represent results 10 inde- <br /> crossed virgin female dicer;esg-gal4&gt;GFP;gal80 &#239;&#172;&#8218;ies. F1            pendent DNA isolates). analysed LIMK2 gene expression <br /> females collected incubation 29&#194;&#176;C 14 days        CRC microarray datasets obtained using Oncomine.25 <br /> effect RNAi. initial Drosophila stocks used described       statistically signi&#239;&#172; decreases LIMK2 expression <br /> previously obtained Bloomington Drosophila            adenocarcinoma samples caecum, colon, colon mucin- <br /> Stock Center.                                                           ous, rectal, rectal mucinous rectosigmoid tissue relative                                                                                                                                    27 <br />                                                                         normal colon tissue (&#239;&#172;?gure 1E; left 26 right . LIMK2 <br /> Human tissue microarrays                                                gene expression signi&#239;&#172;?cantly lower lamina proprial CRC tissue microarray (TMA) constructed containing                epithelial adenomas carcinomas relative matched normal <br /> normal colon mucosa (n=50), primary (n=650) metastatic              cells separated laser capture microdissection <br /> CRC (n=285) previously described O&#226;&#8364;&#8482;Dwyer et al,21                 normal, adenoma carcinoma samples28 (&#239;&#172;?gure 1F). <br /> Hope Murray22 Murray et al.23 metastases               Similarly, LIMK2 expression signi&#239;&#172;?cantly lower carcin- lymph node metastasis corresponding stage 3                omas relative normal colorectal samples independent <br />                                                                                                28              29 <br /> (Dukes C) cancers. histopathology cancers                studies (&#239;&#172;?gure 1G; right . results indicate <br /> reported previously described,21 22 clinicopathological          LIMK2 gene expression frequently signi&#239;&#172;?cantly <br /> details summarised supplementary table S1 (available             reduced CRC. <br /> online . authors con&#239;&#172;?rm tissue samples              examined Limk2 levels murine normal intestines <br /> collected strict institutional review board-approved guide-       intestinal tumours genetically modi&#239;&#172;?ed cancer-prone <br /> lines/protocols informed consent (National Research Ethics         mice. observed Limk2 expression intestines <br /> Service, North Scotland ref. nos. 08/S0801/81 11/NS/             wild-type mice, highest levels base crypts <br /> 0015). collected human tissues treated strict        (&#239;&#172;?gure 2A), higher magni&#239;&#172;?cation &#239;&#172;?dentiality according appropriate applicable laws           marked expression GFP driven promoter protect con&#239;&#172;?dentiality personal information. names            stem cell marker Lgr519 (&#239;&#172;?gure 2B, upper panels). Similarly, identity information revealed              colon sections Limk2 degree development tissue arrays, end users, result         overlap Lgr5 expressing cells (&#239;&#172;?gure 2B, lower panels). exempt consideration Beatson Institute                  Importantly, staining patterns absent mice homo- <br /> Committee Human Subjects Medical Research                  zygous gene-trapped Limk2 loci (&#239;&#172;?gure 2A,B), valid- anonymised non-traceable. Cancer Research UK                  ating antibody use immunohistochemistry. guidelines followed handling analysis           determine Limk2 deletion associated reduced <br /> material.                                                               signalling output, stained sections antibody  <br /> 482                                                                          Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883 <br />                                                                                                                                           Colon <br />  <br />  <br />  <br />  <br /> Figure 1 Limk2 expression human colorectal cancers (CRC).   Western blot mouse embryo &#239;&#172;?broblast cell lysates indicated genotyptes. <br /> *Non-speci&#239;&#172;?c band (B) Western blot human CRC cell lysates. (C) Western blot CRC cell line normal human colon lysates. Equivalent <br /> protein amounts run left lanes, equivalent &#206;&#177;-tubulin amounts run &#239;&#172;?rst left lanes right lane. (D) Western <br /> blot SW48 cell lysates following 48 h treatment indicated novo methyltransferase inhibitor. CpG methylation LIMK2a LIMK2b <br /> promoters 5-azacytidine treatment. Line diagrams indicate position CpG islands (red lines boxed region) relative transcriptional start site promoter. Pie charts indicate proportion methylation multiple independent clones CpG island. <br /> (E) Log2 median-centred LIMK2 messenger RNA expression indicated normal versus adenocarcinoma tissue samples  left side26 right 27 <br /> (F) Log2 median-centered LIMK2 mRNA expression indicated microdissected normal lamina propria epithelia, versus corresponding adenoma carcinoma samples Skrzypczak et al.28 (G) Log2 median-centered LIMK2 mRNA expression normal versus carcinoma samples left 28 <br /> right 29 LIMK2, LIM kinase 2. <br />  <br />  <br /> detects phosphorylation            Limk2 substrate co&#239;&#172;?lin,           crypts, clearly reduced Limk2-KO sections previously validated        co&#239;&#172;?lin protein phosphor-       (&#239;&#172;?gure 2C). <br /> ylation speci&#239;&#172;?city.30 Similar        Limk2, pC&#239;&#172;&#8218; localised               examined Limk2 expression intestinal tumours intestinal cells      highest levels base     hit genetically modi&#239;&#172;?ed mouse model  <br /> Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883                                                                        483 <br />   Colon <br />  <br />  <br />  <br />  <br /> Figure 2 Limk2 expression mouse intestine tumours.   Limk2 expression (red) intestine sections wild-type (WT) Limk2 knockout <br /> (KO) mice (B) Intestine colon sections indicated WT Limk2-KO mice crossed Lgr5&gt;GFP mice cut stained Limk2 (red) expression. Merged image DAPI staining cell nuclei. (C) Intestine sections WT Limk2-KO mice cut stained phosphorylated co&#239;&#172;?lin ( pC&#239;&#172;&#8218;; red). Merged image DAPI staining cell nuclei. (D) Immunohistochemical analysis Limk2 <br /> expression intestinal tumour adjacent normal tissue Ah-Cre:ER, ApcFl/+, PtenFl/+ mouse. (E) &#206;&#178;-Galactosidase activity normal dysplastic crypts detected X-gal staining frozen intestinal tissue sections heterozygous Limk2 gene-trap, Ah-Cre, ApcFl/+, PtenFl/+ mice. <br />  <br />  <br /> requires stochastic loss heterozygosity Apc Pten.31                data indicate apparently high expression Limk2 expression Ah-Cre:ER, Apc Fl/+, Pten Fl/+ mice                   Limk2 mouse intestinal cells repressed, probably markedly lower tumours surrounding normal tissue                   promoter methylation consequent inhibition, (&#239;&#172;?gure 2D; tumour border outlined red dashed line). Mice                 tumorigenesis. <br /> bearing copy &#206;&#178;-galactosidase gene-trap Limk2                     determine patterns LIMK2 expression changes <br /> locus context Ah-Cre:ER, ApcFl/+, PtenFl/+ genotype               associated oncogenesis tumour progression, showed reduced &#206;&#178;-galactosidase activity (visualised X-gal)               used LIMK2 antibody stain representative human intes- dysplastic crypts compared normal crypts, indicating inhib-             tinal adenoma samples. Similar normal tissue, LIMK2 expres- <br /> ition Limk2 promoter transcriptional activity (&#239;&#172;?gure 2E).                  sion relatively high low grade adenomas markedly <br />  <br /> 484                                                                                 Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883 <br />                                                                                                                                      Colon <br />  <br />  <br />  <br />  <br /> Figure 3 LIM kinase 2 (LIMK2) expression human colorectal cancer (CRC) progression.   Immunohistochemical analysis LIMK2 expression human intestinal low grade high grade adenomas. (B) Immunohistochemical analysis LIMK2 expression tissue microarray (TMA) human colorectal tumours lymph node metastases. (C) LIMK2 staining intensities TMA human CRC. (D) Cumulative survival curves high low LIMK2 expressing patients. <br />  <br /> decreased high grade adenomas low high levels               supplementary table S2, available online . LIMK2 expres- <br /> dysplasia (&#239;&#172;?gure 3A). stained characterised TMA            sion lymph node metastases signi&#239;&#172;?cantly lower comprised 650 patient samples normal intestines                 stages Dukes C (&#239;&#172;?gure 3B,C, supplementary table S2, <br /> tissue Dukes Dukes C tumours, representa-            available online . determine association tive lymph node metastases.21 assigning staining intensity             LIMK2 expression survival, grouped staining categories <br /> scores 1 (low) 6 (high), established median               low (scores 1&#226;&#8364;&#8220;3) high (scores 4&#226;&#8364;&#8220;6) staining intensity normal intestines scored 5 relatively          patients low LIMK2 expression signi&#239;&#172;?cantly <br /> little variation (&#239;&#172;?gure 3B,C). LIMK2 expression progressively             (&#207;&#8225;2=14.51, p&lt;0.001; log rank Mantel&#226;&#8364;&#8220;Cox test) lower mean <br /> dropped tumours, Dukes stage having signi&#239;&#172;?cantly             survival times (93.9 months) high LIMK2 expressing <br /> lower LIMK2 expression predecessor (&#239;&#172;?gure 3B,C,              patients (118.2 months) (&#239;&#172;?gure 3D supplementary table <br />  <br /> Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883                                                                    485 <br />   Colon <br />  <br />  <br />  <br />  <br /> Figure 4 Phosphorylated co&#239;&#172;?lin human colorectal cancer (CRC) progression.   Immunohistochemical analysis pCFL expression tissue <br /> microarray (TMA) human colorectal tumours lymph node metastases. (B) pCFL staining intensities TMA human CRC. (C) Cumulative <br /> survival curves high low pCFL-expressing patients. <br />  <br /> S3, available online . median mean survival            positive pixel algorithm32 33 yielded Pearson product&#226;&#8364;&#8220;moment <br /> times estimated scoring rank, clear            correlation coef&#239;&#172;?cient r=0.59 (&#239;&#172;?gure 5B). trend highest survival patients scoring 6 lowest sur-        LIMK2 pCFL variables analysed  best patient <br /> vival patients scoring 1  supplementary table S4, avail-         mean survival time high LIMK2 pCFL <br /> able online . determine reduced LIMK2                    (118.9 months, 38.7% total patients; &#239;&#172;?gure 5C, supple- <br /> expression levels associated lower signalling output,          mentary table S8, available online , worst mean sur- stained TMA antibody detects co&#239;&#172;?lin phos-           vival time low LIMK2 pCFL (84.6 months, 36.1% <br /> phorylation.30 Levels pCFL signi&#239;&#172;?cantly progres-             total patients; &#239;&#172;?gures 5C, supplementary table S8, avail- <br /> sively reduced relative normal intestine             able online . data reveal clear patterns reduced <br /> Dukes stage, exceptions pCFL Dukes B tumours            LIMK2 expression activity CRC, signi&#239;&#172; associ- <br /> did differ Dukes  did pCFL lymph node                  ation patient mortality. <br /> metastases differ Dukes C tumours (&#239;&#172;?gures 4A,B, supplementary table S5, available online . Mean patient             LIMK2 promoter methylation human tumours <br /> survival signi&#239;&#172;?cantly (&#207;&#8225;2=14.81, p&lt;0.001; log-rank                   DNMT inhibitor-sensitive promoter methylation CRC <br /> Mantel&#226;&#8364;&#8220;Cox test) longer high pCFL patients (119.3 months)             cell line (&#239;&#172;?gure 1D) suggested similar effect promoter low pCFL patients (91.2 months) (&#239;&#172;?gure 4C                methylation account reduction LIMK2 expres- <br /> supplementary table S6, available online .                 sion human tumours (&#239;&#172;?gure 3). isolating genomic DNA <br /> median mean survival times estimated pCFL              frozen tumour sections represented TMA scoring rank, clear trend highest survival          matched normal tissue isolated patients, patients scoring 6 lowest survival patients scoring 1         able compare patterns promoter methylation using <br /> supplementary table S7, available online . examining           bisul&#239;&#172;?te sequencing. seven CpG islands LIMK2a patient patient basis, obvious correlation          LIMK2b promoters typically methylated tumours LIMK2 expression pCFL levels (&#239;&#172;?gure 5A),               matched normal tissues (results patient example compared using SlidePath tissue image analysis           depicted &#239;&#172;?gure 6A). percentages CpG island <br />  <br /> 486                                                                            Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883 <br />                                                                                                                                      Colon <br />  <br />  <br />  <br />  <br /> Figure 5 Association LIM kinase 2 (LIMK2) expression co&#239;&#172;?lin phosphorylation patient outcomes.   Staining LIMK2 pCFL paired patient sections. (B) LIMK2 pCFL staining intensities measured using SlidePath tissue image analysis positive pixel <br /> algorithm.32 33 (C) Distribution outcomes combinations high low LIMK2 pCFL. <br />  <br />  <br /> methylation LIMK2a LIMK2b promoters compiled                 increased stem cell proliferation.42 measure patients, signi&#239;&#172;?cantly higher CpG methyla-             dLIMK reduction affected cell proliferation directly, &#239;&#172;?xed <br /> tion tumours compared matched normal tissues.                 midguts stained phosphorylated Histone 3 ( pH3) <br /> results support conclusion reduced LIMK2 expression              antibody marker mitotic cells.41 pH3 staining human CRC increased promoter methylation.                    low absent midguts wild-type &#239;&#172;&#8218;ies                                                                           homeostatic conditions, dLIMK knockdown independ- <br /> Stem cell homeostasis D melanogaster midgut                            ent RNAi transgenes signi&#239;&#172;?cantly ( p&lt;0.001) increased understand repression LIMK2 expression                mean number pH3-positive cells relative control geno- <br /> tribute CRC, used D melanogaster genetically tract-            type &#239;&#172;?vefold (&#239;&#172;?gure 7D,E). staining DAPI <br /> able model examine role LIM kinase                    revealed patterns condensed chromatin supported gastrointestinal homeostasis.34&#226;&#8364;&#8220;36 Importantly, experiments            conclusion pH3-positive cells mitotic (&#239;&#172;?gure 7D, right Drosophila posterior midgut, homologous               panels). Haematoxylin eosin (H<span id='am-12' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-13' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-18' property="rdfs:label" content="AMP" datatype="xsd:string"></span>amp</span>;E) stained cross-sections <br /> mammalian intestine, established orthologues             paraf&#239;&#172;?n-embedded posterior midguts control &#239;&#172;&#8218;ies genes frequently mutated human CRC   APC, &#206;&#178;-catenin,                typical appearance, continuous cell layer sur- ) play important roles regulation intestinal stem           rounding substantial lumen (&#239;&#172;?gure 6D, left panel). contrast, <br /> cell proliferation tissue homeostasis.37&#226;&#8364;&#8220;39 used                   H&amp;E stained midgut cross-sections UAS-dLIMK RNAi &#239;&#172;&#8218;ies <br /> inverted-repeat RNA interference transgenes (RNAi)              signi&#239;&#172;?cantly thicker (&#239;&#172;?gure 6D, right panel, &#239;&#172;?gure 7G). <br /> transcriptional control Gal4/UAS (upstream activating              data indicate Drosophila, LIM kinase normally <br /> sequence) system40 reduce expression single                     contributes intestinal homeostasis limiting proliferation <br /> Drosophila LIM kinase homologue (dLIMK) stem cells                     stem cells. <br /> expressing transcription factor Gal4 driven escargot <br /> (esg) promoter.41 dLIMK knocked esg-Gal4                 LIMK2 deletion increases Lgr5-positive mouse intestinal <br /> driven expression UAS-dLIMK RNAi &#239;&#172;&#8218;ies carrying               stem cells <br /> UAS-GFP transgene mark stem cells, readily apparent             wished determine conserved  compared control &#239;&#172;&#8218;ies (wild-type), dLIMK knockdown               role Limk2 regulating mouse intestinal stem cell homeo- <br /> signi&#239;&#172;?cantly increased proportion GFP-expressing stem              stasis. Using method allows isolation long- <br /> cells/progenitor cells (&#239;&#172;?gure 7A,B) demarcated          term vitro propagation self-renewing intestinal epithelial relatively elevated expression &#206;&#178;-catenin homologue           cells,15 examined Limk2 deletion affected prolifer- <br /> Armadillo Delta (&#239;&#172;?gure 7C). phenotype consistent              ation Lgr5-positive stem cell population.19 initially <br />  <br /> Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883                                                                   487 <br />   Colon <br />  <br />  <br />  <br />  <br /> Figure 6 CpG methylation LIMK2a LIMK2b promoters normal tumour tissue.   Line diagrams indicate position CpG islands (red <br /> lines boxed region) relative transcriptional start site promoter. Pie charts indicate proportion methylation multiple <br /> independent clones CpG island genomic DNA representative patient. (B) Cumulative LIMK2a LIMK2b promoter methylation <br /> data matched normal tumour tissue derived patients. <br />  <br /> isolated wild-type Limk2-KO mice, intestinal epithelial              increased number cells indistinguishable cells showed signi&#239;&#172; differences expression                  wild-type stem cell counterparts. inference, epigenetic <br /> various stem cell markers western blotting RNA micro-                  modi&#239;&#172;?cations LIMK2 promoters resulted tran- <br /> array  supplementary &#239;&#172;?gure S1A,B, available online ,                scriptional repression positively selected human percentages Lgr5&gt;GFP-expressing cells did                  CRC increased response stem cells inducers signi&#239;&#172;?cantly differ  supplementary &#239;&#172;?gure S1C, available              proliferation. <br /> online .  cells cultured passaged <br /> twice  7 days) presence proliferation-inducing           Limk2 deletion promotes crypt dysplasia tumour size growth factors epidermal growth factor, R-spondin1                       mouse model colitis-associated CRC <br /> Noggin embedded dimensional Matrigel,                   test effect LIMK2 deletion mouse model greater proportion Lgr5&gt;GFP-positive cells                   colitis-associated CRC, 6&#226;&#8364;&#8220;12-week-old mice injected Limk2-KO organoids relative wild-type revealed                      single dose AOM (12.5 mg/kg), potent carcinogen immuno&#239;&#172;&#8218;uorescence microscopy (&#239;&#172;?gure 8A; white arrows illus-                  induces formation O6-methyl-<span id='am-24' about='obo:IMR_0200319' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-25' property="oboInOwl:id" content="IMR:0200319" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasDbXref" content="KEGG:C00242" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="Guanine" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>guanine</span>, followed trating example GFP-positive cells). cells multiple                cycles DSS administration drinking water (&#239;&#172;?gure 9A). <br /> independent organoids dissociated GFP-expressing                    DSS administration cause chronic in&#239;&#172;&#8218;ammation, enhancing <br /> cells counted FACS (&#239;&#172;?gure 8B, 10 000 events gated                 incidence AOM-induced tumours.43 Limk2-de&#239;&#172;?cient <br /> dition), signi&#239;&#172; ( p&lt;0.05, Student&#226;&#8364;&#8482;s t test)                  mice display higher sensitivity AOM+DSS protocol <br /> increase percentage Lgr5&gt;GFP-positive stem cells                signi&#239;&#172; increase weight variation (&#239;&#172;?gure 9B,C), Limk2-KO relative wild-type (&#239;&#172;?gure 8C). Western blotting              re&#239;&#172;&#8218;ecting increased weight loss second lysates multiple independent organoids corroborated                 DSS cycles. end treatment regimen, Limk2-KO <br /> elevation Lgr5 driven GFP expression (indicating greater                mice marked increase crypt-villus dysplasia hyper- <br /> proportion GFP-positive cells) Limk2-KO (&#239;&#172;?gure 8D).                plasia middle distal colon (&#239;&#172;?gure 9D). GFP-positive cells isolated collected &#239;&#172;&#8218;ow                   caecum displayed severe dysplastic hyperproli- <br /> cytometry, RT-PCR analysis revealed signi&#239;&#172; differences                ferative phenotype, common feature expression number stem cell markers including                 tumour model (&#239;&#172;?gure 9D,E). marked trend <br /> Lgr5, Bmi1, Olfm4, CD44 Ascl2 wild-type                  higher tumour incidence Limk2-KO mice (&#239;&#172;?gure <br /> Limk2-KO, indicating equivalent levels &#226;&#8364;&#732;stemness&#226;&#8364;&#8482;                  9F). tumours adenomas high &#206;&#178;-catenin <br /> GFP-positive cells genotype (&#239;&#172;?gure 8E). results              expression. striking signi&#239;&#172; effects indicate conditions strongly promote prolif-             histology volume &#206;&#178;-catenin-positive tumour foci <br /> eration intestinal stem cells, deletion Limk2 provides           Limk2-KO mice. Limk2-KO foci signi&#239;&#172;?cantly larger <br /> competitive advantage relative wild-type cells, giving rise            (&#239;&#172;?gure 9G) locally invasive, showing higher grade  <br /> 488                                                                                Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883 <br />                                                                                                                                     Colon <br />  <br /> Figure 7 Knockdown dLIMK <br /> increases Drosophila intestinal stem <br /> cell proliferation tissue thickening. <br />   Fly intestinal stem progenitor <br /> cells marked esg-driven GFP endogenous Armadillo (red) <br /> expression, &#239;&#172;&#8218;ies expressing dLIMK <br /> RNAi inverted repeat hairpins increased stem cell numbers compared control genotype (wild-type; <br /> WT). (B) GFP/DAPI-positive cells counted &#239;&#172;?ve sections &#239;&#172;?ve WT dLIMK siRNA &#239;&#172;&#8218;y lines. <br /> (C) Cells expressing esg&gt;GFP marked elevated expression Armadillo Delta relative neighbouring cells. (D) Proliferation <br /> determined staining mitotic <br /> marker phosphorylated Histone 3 <br /> ( pH3) control (WT) dLIMK <br /> targeting RNAi. Higher magni&#239;&#172;?cation <br /> images pH3 DAPI staining <br /> reveal appearance condensed <br /> chromosomes mitotic cells. <br /> (E). Quanti&#239;&#172;?cation pH3 numbers &#239;&#172;&#8218;ies expressing independent <br /> dLIMK RNAi hairpins revealed <br /> statistically signi&#239;&#172; increases relative control WT &#239;&#172;&#8218;ies. (F) Cross-sections &#239;&#172;?xed H&amp;E stained midguts control (WT) dLIMK RNAi-expressing <br /> &#239;&#172;&#8218;ies. (G) Average gut wall widths <br /> determined separate <br /> measurements cross-section &#239;&#172;?ve WT dLIMK RNAi &#239;&#172;&#8218;ies. <br /> *p&lt;0.05 Student&#226;&#8364;&#8482;s t test. <br />  <br />  <br />  <br />  <br /> dysplasia (&#239;&#172;?gure 9E,G). results indicate                   gastrointestinal homeostasis tumorigenesis,44 using <br /> removal Limk2 colitis-associated CRC mouse model                  intestinal epithelial cells isolated genetically modi&#239;&#172;?ed mice. mild effect tumour initiation, signi&#239;&#172;              studies revealed conserved role LIMK2 constrain- <br /> impact tumour growth acquisition                  ing gastrointestinal stem cells Drosophila mice, invasive phenotype. relief                relief constraint allowed expansion stem cell <br /> proliferative constraint gastrointestinal stem cells         numbers. Given accumulating evidence indicates stem <br /> ditions favour continuous self-renewal, contrib-          cells predominant cells origin colorectal <br /> uting CRC.                                                             tumours,2&#226;&#8364;&#8220;5 logical conclusion study                                                                           positive selection reduced LIMK2 expression activity <br /> DISCUSSION                                                                CRC initiation progression allow propagation LIMK2 expression reduced intestinal              gastrointestinal stem cells. Consistent conclusion, <br /> tumours cancer-prone genetically modi&#239;&#172;?ed mice,           genetic deletion Limk2 reduce expression AOM/ <br /> human CRC cell lines tumours. gain insight                DSS colitis-associated CRC mouse model resulted increased <br /> potential roles LIMK2, undertook genetic analysis            average intestinal tumour volume severe dysplastic <br /> Drosophila midgut, emerging informative model              hyperproliferative phenotype. <br />  <br /> Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883                                                                  489 <br />   Colon <br />  <br /> Figure 8 Limk2 deletion increases <br /> cultured mouse intestinal stem cell <br /> proportion.   Self-renewing intestinal <br /> epithelial cells isolated wild-type (WT) Limk2 knockout <br /> (KO) mice propagated vitro presence growth factors <br /> EGF, R-spondin1 Noggin embedded dimensional <br /> Matrigel. Organoids &#239;&#172;?xed, <br /> stained &#239;&#172;?lamentous actin phalloidin, visualised Lgr5-driven GFP expression phalloidin staining confocal <br /> microscopy. (B) Organoids isolated disrupted yield single <br /> cell suspensions. brief <br /> incubation propidium iodide (PI), <br /> FACS analysis 10 000 PI-negative <br /> live cells used determine proportion Lgr5&gt;GFP-positive cells genotype. (C) Graph results independent FACS <br /> experiments. *p&lt;0.05 Student&#226;&#8364;&#8482;s t <br /> test. (D) Equivalent cell numbers disrupted organoids intestinal <br /> epithelial cells WTand Limk2 KO <br /> mice used prepare cell <br /> lysates western blotted indicated. (E) RT-PCR analysis stem <br /> cell marker expression sorted <br /> GFP-positive cells WT Limk2-KO mice expressing Lgr5&gt;GFP. expression levels indicated <br /> stem cell marker did vary <br /> signi&#239;&#172;?cantly WT Limk2-KO mice, indicating equivalent <br /> &#226;&#8364;&#732;stemness&#226;&#8364;&#8482;. <br />  <br />  <br />  <br />  <br />   reduced LIMK2 expression CRC surprising given           invasion, reports negative roles LIM kinase functions reports elevated LIM kinase expression cancers       cell cycle regulation overlooked. <br /> including breast,10 11 malignant melanoma12 prostate13           Elevated LIMK2 levels following DNA damage tumours. role LIM kinases regulating acto-      promote G2/M arrest co&#239;&#172;?lin,46 consistent myosin cytoskeletal dynamics, assumed         proposed role LIMK2 mitosis regulating micro- consistently elevated LIM kinase expression              tubule organisation spindle orientation.47 48 Given advanced cancers drive local invasion distant metastasis.     expression LIMK2a LIMK2b variants  showed inhibition LIM kinase activity          reported reduced thyroid cancers,46 important <br /> RNAi <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span><span id='am-3' property="rdfs:label" content="chemical" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>chemical</span> inhibition blocked collective invasion       consider LIMK2 contributes speci&#239;&#172;?c cancers breast cancer squamous cell carcinomas blocking           attempting construct uni&#239;&#172;?ed theory. <br /> invasive ability leading cells using vitro dimensional     actual fact, role LIM kinases regulating co&#239;&#172;?lin <br /> invasion models.45  focusing LIM kinase            phosphorylation &#239;&#172;?lamentous actin turnover nuanced, activity in&#239;&#172;&#8218;uences processes involved cell motility           circumstances actually favourable  <br /> 490                                                                       Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883 <br />                                                                                                                                     Colon <br />  <br /> Figure 9 Limk2 deletion increases <br /> tumour volume dysplasia colitis-associated colorectal cancer <br /> mouse model.  . Timeline experimental procedure. (B) Mean <br /> weights wild-type Limk2 <br /> knockout mice experimental <br /> procedure relative starting weight <br /> (100%). (C) Coef&#239;&#172;?cient variation weight curves wild-type Limk2 <br /> knockout mice. *p&lt;0.05 Student&#226;&#8364;&#8482;s t <br /> test. (D) Cross-sections colon caecum wild-type Limk2 <br /> knockout mice indicated. Boxes <br /> indicate regions depicted higher <br /> magni&#239;&#172;?cation images. (E) Serial <br /> sections colon tissue wild-type Limk2 knockout mice indicated. <br /> Boxes indicate regions depicted higher magni&#239;&#172;?cation images. Elevated <br /> &#206;&#178;-catenin staining relative surrounding tissue used identify <br /> tumours de&#239;&#172;?ne dimensions. <br /> (F) Number &#206;&#178;-catenin-positive foci colon section wild-type Limk2 knockout mice indicated. p <br /> Value Student&#226;&#8364;&#8482;s t test. (G) Volume &#206;&#178;-catenin-positive foci wild-type Limk2 knockout mice indicated. *p&lt;0.05 Student&#226;&#8364;&#8482;s t test. <br />  <br />  <br />  <br />  <br /> increased invasive ability reduced LIM kinase             gastrointestinal stem cells, additional contributions <br /> expression activity. previously ectopic expres-         reduced LIMK2 signal output <span id='am-6' about='obo:IMR_0001658' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-7' property="obo:IAO_0000115" content="An atom that has either gained or lost electrons to acquire a chage; for example Na+ and Cl-." datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasDbXref" content="CHEBI:24870" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-10' property="rdfs:label" content="ion" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:id" content="IMR:0001658" datatype="xsd:string"></span>ion</span> promoting tumour cell inva- <br /> sion LIMK1 decreased motility Ras-transformed Swiss             siveness. result, actually distinct ways 3T3 &#239;&#172;?broblasts,49 overexpression LIMK1 MTLn3                  reduction LIMK2 expression contributes CRC; rat mammary carcinoma cells inhibited lamellipod extensions,50            relief constraints stem cells early tumorigenesis, EGF-stimulated motility, vivo invasion.51 relative             promoting cell invasiveness advanced stages. <br /> proportions LIM kinase co&#239;&#172;?lin, activity             inference study LIMK2 levels <br /> co&#239;&#172;?lin phosphatases Slingshot, contribute regulating           decreased sizeable proportion CRC patients, co&#239;&#172;?lin activity cycle key determinant invasive         cancers effectively treated che- metastatic potential.52 53 continuous decreases                motherapeutics knocking inhibiting <br /> LIMK2 expression co&#239;&#172;?lin phosphorylation advancing                LIMK2 sensitises cancer cells DNA damaging agents,17 <br /> tumour grade suggests  addition effects                 Aurora inhibitors,54 Ras inhibition55 microtubule- <br />  <br />  <br /> Louren&#195;&#167;o FC, et al. Gut 2014;63:480&#226;&#8364;&#8220;493. doi:10.1136/gutjnl-2012-303883                                                                  491 <br />   Colon <br />  <br /> destabilising drugs vincristine vinblastine.56                                     19   Barker N, van Es JH, Kuipers J, et al. Identi&#239;&#172;?cation stem cells small intestine  knowledge LIMK2 expression levels CRC                                          colon marker gene Lgr5. Nature 2007;449:1003&#226;&#8364;&#8220;7. <br />                                                                                                20   Cordero JB, Macagno JP, Stefanatos RK, et al. Oncogenic Ras diverts host TNF utility patient strati&#239;&#172;?cation development                                    tumor suppressor activity tumor promoter. Dev Cell 2010;18:999&#226;&#8364;&#8220;1011. <br /> sonalised therapies.                                                                           21   O&#226;&#8364;&#8482;Dwyer D, Ralton LD, O&#226;&#8364;&#8482;Shea  et al. proteomics colorectal cancer: <br />                                                                                                     identi&#239;&#172;?cation protein signature associated prognosis. PLoS 2011;6: <br /> Acknowledgements authors like thank Colin Nixon colleagues                         e27718. histology services biological research service Beatson Institute          22   Hope NR, Murray GI. expression pro&#239;&#172;?le RNA-binding proteins primary Cancer Research. acknowledge support Think Pink breast cancer                  metastatic colorectal cancer: relationship heterogeneous nuclear <br /> group funded purchase NDP slide scanner.                                                 ribonucleoproteins prognosis. Hum Pathol 2011;42:393&#226;&#8364;&#8220;402. <br /> Contributors Study concept design: FCL, JC, MV, GIM, MFO; acquisition                   23   Murray GI, Patimalla S, Stewart KN, et al. Pro&#239;&#172;?ling expression cytochrome <br /> data: FCL, JM, JB,  GIM, MFO; analysis interpretation data: FCL, JC, OJS,                 P450 breast cancer. Histopathology 2010;57:202&#226;&#8364;&#8220;11. <br /> MV, GIM, MFO; drafting manuscript: FCL, MFO; critical revision                   24   Foulks JM, Parnell KM, Nix RN, et al. Epigenetic drug discovery: targeting DNA <br /> manuscript important intellectual content: FCL, OJS, MV, GIM, MFO; statistical                  methyltransferases. J Biomol Screen 2012;17:2&#226;&#8364;&#8220;17. <br /> analysis: FCL, GIM, MFO; obtained funding: OJS, MV, GIM, MFO; administrative,                  25   Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: cancer microarray database technical, material support: RS, KS, SMF.                                                        integrated data-mining platform. Neoplasia 2004;6:1&#226;&#8364;&#8220;6. <br />                                                                                                26   Kaiser S, Park YK, Franklin JL, et al. Transcriptional recapitulation subversion Funding study funded Cancer Research UK.                                                embryonic colon development mouse colon tumor models human colon <br /> Competing interests                                                                            cancer. Genome Biol 2007;8:R131. <br />                                                                                                27   Cancer Genome Atlas Network. Comprehensive molecular characterization Patient consent Obtained.                                                                           human colon rectal cancer. Nature 2012;487:330&#226;&#8364;&#8220;7. <br /> Ethics approval tissue samples collected strict institutional review            28   Skrzypczak M, Goryca K, Rubel T, et al. Modeling oncogenic signaling colon <br /> board-approved guidelines/protocols informed consent (National Research                        tumors multidirectional analyses microarray data directed maximization Ethics Service, North Scotland).                                                                 analytical reliability. PLoS 2010;5:e13091. <br />                                                                                                29   Hong Y, Downey T, Eu KW, et al. &#226;&#8364;&#732;metastasis-prone&#226;&#8364;&#8482; signature early-stage <br /> Provenance peer review commissioned; externally peer reviewed. <br />                                                                                                     mismatch-repair pro&#239;&#172;?cient sporadic colorectal cancer patients implications Data sharing statement Data shared request.                                              possible therapeutics. Clin Exp Metastasis 2010;27:83&#226;&#8364;&#8220;90. <br /> Open Access Open Access article distributed accordance Creative         30   Samuel MS, Lopez JI, McGhee EJ, et al. Actomyosin-mediated cellular tension drives <br /> Commons Attribution Non Commercial (CC NC 3.0) license, permits                  increased tissue stiffness &#206;&#178;-catenin activation induce epidermal hyperplasia <br /> distribute, remix, adapt, build work non-commercially, license                  tumor growth. Cancer Cell 2011;19:776&#226;&#8364;&#8220;91. <br /> derivative works different terms, provided original work properly cited      31   Marsh V, Winton DJ, Williams GT, et al. Epithelial Pten dispensable intestinal <br /> use non-commercial.  http://creativecommons.org/licenses nc/3.0/                          homeostasis suppresses adenoma development progression Apc <br />                                                                                                     mutation. Nat Genet 2008;40:1436&#226;&#8364;&#8220;44. <br />                                                                                                32   Conway C, Dobson L, O&#226;&#8364;&#8482;Grady  et al. Virtual microscopy enabler                                                                                                     automated/quantitative assessment protein expression TMAs. Histochem Cell <br /> REFERENCES                                                                                          Biol 2008;130:447&#226;&#8364;&#8220;63. <br />  1    Davies EJ, Marsh V, Clarke AR. Origin maintenance intestinal cancer           33   Mohammed ZM, Going JJ, McMillan DC, et al. Comparison visual       stem cell. Mol Carcinog 2011;50:254&#226;&#8364;&#8220;63.                                                       automated assessment HER2 status impact outcome primary <br />  2    Schepers AG, Snippert HJ, Stange  et al. Lineage tracing reveals Lgr5+ stem cell           operable invasive ductal breast cancer. Histopathology 2012;61:675&#226;&#8364;&#8220;84. <br />       activity mouse intestinal adenomas. Science 2012;337:730&#226;&#8364;&#8220;5.                           34   Polesello C, Roch F, Gobert V, et al. Modeling cancers Drosophila. Prog Mol Biol <br />  3    Barker N, Ridgway RA, van Es JH, et al. Crypt stem cells cells origin            Transl Sci 2011;100:51&#226;&#8364;&#8220;82. <br />       intestinal cancer. Nature 2009;457:608&#226;&#8364;&#8220;11.                                               35   Rudrapatna VA, Cagan RL, Das TK. Drosophila cancer models. Dev Dyn <br />  4    Merlos-Suarez  Barriga FM, Jung P, et al. intestinal stem cell signature                2012;241:107&#226;&#8364;&#8220;18. <br />       identi&#239;&#172;?es colorectal cancer stem cells predicts disease relapse. Cell Stem Cell      36   Cordero JB, Sansom OJ. Wnt signalling role stem cell-driven intestinal <br />       2011;8:511&#226;&#8364;&#8220;24.                                                                                regeneration hyperplasia. Acta physiol 2012;204:137&#226;&#8364;&#8220;43. <br />  5    Ziskin JL, Dunlap D, Yaylaoglu M, et al. situ validation intestinal stem cell   37   Lee WC, Beebe K, Sudmeier L, et al. Adenomatous polyposis coli regulates <br />       signature colorectal cancer. Gut 2013;62:1012&#226;&#8364;&#8220;23.                                          Drosophila intestinal stem cell proliferation. Development 2009;136:2255&#226;&#8364;&#8220;64. <br />  6    Olson MF, Sahai E. actin cytoskeleton cancer cell motility. Clin Exp              38   Lin G, Xu N, Xi R. Paracrine Wingless signalling controls self-renewal Drosophila <br />       Metastasis 2009;26:273&#226;&#8364;&#8220;87.                                                                    intestinal stem cells. Nature 2008;455:1119&#226;&#8364;&#8220;23. <br />  7    Samuel MS, Olson MF. Dying  tale rho. Cell Stem Cell 2010;7:135&#226;&#8364;&#8220;6.            39   Cordero J, Vidal M, Sansom O. APC master regulator intestinal homeostasis <br />  8    Scott RW, Olson MF. LIM kinases: function, regulation association human              transformation: &#239;&#172;&#8218;ies vertebrates. Cell Cycle 2009;8:2926&#226;&#8364;&#8220;31. <br />       disease. J Mol Med 2007;85:555&#226;&#8364;&#8220;68.                                                       40   Brand AH, Perrimon N. Targeted gene expression means altering cell fates <br />  9    Manetti F. Recent &#239;&#172;?ndings con&#239;&#172;?rm LIM domain kinases emerging target                        generating dominant phenotypes. Development 1993;118:401&#226;&#8364;&#8220;15. <br />       candidates cancer therapy. Curr Cancer Drug Targets 2012;12:543&#226;&#8364;&#8220;60.                  41   Micchelli CA, Perrimon N. Evidence stem cells reside adult Drosophila <br /> 10    Bagheri-Yarmand R, Mazumdar  Sahin AA, et al. LIM kinase 1 increases tumor                  midgut epithelium. Nature 2006;439:475&#226;&#8364;&#8220;9. <br />       metastasis human breast cancer cells regulation urokinase-type             42   Jiang H, Patel PH, Kohlmaier  et al. Cytokine/Jak/Stat signaling mediates <br />       plasminogen activator  Int J Cancer 2006;118:2703&#226;&#8364;&#8220;10.                                  regeneration homeostasis Drosophila midgut. Cell 2009;137:1343&#226;&#8364;&#8220;55. <br /> 11    McConnell BV, Koto K, Gutierrez-Hartm <br /> </body></html>